Updates from The Motley Fool

Latest updates on Cytokinetics, Inc. from Fool.com.

Stock Performance

CYTK vs. S&P 500 | 2 Year Performance
CYTK 1-Day Stock Chart
CYTK 5-Day Stock Chart
CYTK 1-Month Stock Chart
CYTK 3-Month Stock Chart
CYTK 6-Month Stock Chart
CYTK 1-Year Stock Chart
CYTK 2-Year Stock Chart
CYTK 5-Year Stock Chart
View Interactive CYTK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cytokinetics, Inc..
Current Price: $8.07
Prev Close: $8.21
Open: $8.20
Bid: $8.08
Ask: $8.10
Day's Range: $7.97 - $8.27
52wk Range: $5.88 - $13.18
Volume: 166,669
Avg Vol 277,755
Market Cap: $313.50M
P/E (ttm): -7.82
EPS (ttm): -$1.05
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cytokinetics, Inc..
CAPS Rating 2 out of 5
166 Outperform
18 Underperform
CAPS All Stars
34 Outperform
5 Underperform

How do you think Cytokinetics, Inc. will perform against the market?

You pick for Cytokinetics, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert I. Blum, CEO

64% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cytokinetics, Inc..

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers